Brief: Chemours Q1 Adjusted EPS USD 0.05 Vs. IBES Estimate USD -0.05
05/05/2026 21:59
May 05 (Reuters) - Chemours Q1 sales USD 1,400 million vs. IBES estimate USD 1,387 million. Q1 adjusted net income USD 8 million vs. IBES estimate USD -5.56 million Q1 adjusted EBITDA USD 169 million vs. IBES estimate USD 138.1 million
Recent news on The Chemours
See all newsUS RESEARCH ROUNDUP-Essex Property Trust, Qualys, Vulcan Materials
3M, DuPont must face Connecticut firefighters' lawsuit over 'forever chemicals'
Chemours, DuPont, Corteva settle North Carolina 'forever chemicals' claims for $455 million
U.S. RESEARCH ROUNDUP-Argan, Mastec, Oracle
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval